FDA publishes a draft revising a 2013 guidance on a CGMP framework for preventing cross-contamination in non-penicillin beta-lactam drugs.
FDA says the Baxter Healthcare recall of its Volara system due to risk of respiratory distress in home use is Class 1.
The Vermont federal court approves a consent decree of permanent injunction against Colchester, VT-based Edge Pharm, a compound pharmacy accused of ma...
FDA clears the Medtronic LigaPASS ligament augmentation system.
FDA approves an expanded indication for Mercks Vaxneuvance (pneumococcal 15-valent conjugate vaccine) to include children six weeks through 17 years o...
Alliance for Pharmacy Compounding CEO Scott Brunner calls on FDA to abandon current efforts to draft a drug compounding memorandum of understanding wi...
FDA and the National Center for Advancing Translational Sciences update the CURE ID crowd-sourcing drug repurposing app.
The LUNGevity Foundation says many lung cancer therapies are in development, including some relying on biomarkers.